MARK L. STURDEVANT HEPATOBILIARY/PANCREATIC SURGERY Professor of Clinical Surgery; Chief, Division of Hepatobiliary and ...

Adding lanreotide to everolimus significantly prolonged progression-free survival compared with everolimus alone in patients ...

The findings suggest that "supportive care and management of geriatric vulnerabilities at baseline may improve outcomes and ...

Dr. Susumu Hijioka spoke about the benefit of this combination therapy in patients with unresectable or recurrent GEP-NETs, ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...

Exelixis (EXEL) announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...

Afinitor plus Somatuline showed an improved survival compared with Afinitor monotherapy in patients with gastroenteropancreatic neuroendocrine tumors.

Perthera, a leader in precision oncology, will present follow-on research and validation of the world's first AI-driven chemo ...

Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, today provided details from the abstracts featuring pelareorep ...

BPGbio shares results of Project Survival clinical trial identifying novel pancreatic cancer patient subtypes at ASCO GI 2025 ...

SEATTLE, Jan. 22, 2025 (GLOBE NEWSWIRE) -- ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers through ...